Innovation1 Biotech (Innovation1 Biotech) COGS-to-Revenue : 0.00 (As of Aug. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Innovation1 Biotech COGS-to-Revenue?

Innovation1 Biotech's Cost of Goods Sold for the three months ended in Aug. 2023 was $0.00 Mil. Its Revenue for the three months ended in Aug. 2023 was $0.00 Mil.

Innovation1 Biotech's COGS to Revenue for the three months ended in Aug. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Innovation1 Biotech's Gross Margin % for the three months ended in Aug. 2023 was N/A%.

Innovation1 Biotech COGS-to-Revenue Historical Data

The historical data trend for Innovation1 Biotech's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovation1 Biotech COGS-to-Revenue Chart

Innovation1 Biotech Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

COGS-to-Revenue

Get a 7-Day Free Trial

1.13

3.00

0.33

Innovation1 Biotech Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Innovation1 Biotech COGS-to-Revenue Calculation

Innovation1 Biotech's COGS to Revenue for the fiscal year that ended in Aug. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Innovation1 Biotech's COGS to Revenue for the quarter that ended in Aug. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Innovation1 Biotech (OTCPK:IVBT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Innovation1 Biotech's Gross Margin % for the three months ended in Aug. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Innovation1 Biotech COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Innovation1 Biotech's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovation1 Biotech (Innovation1 Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Innovation1 Biotech Inc (OTCPK:IVBT) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Wall Street, Suite 2701, New York, NY, USA, 10005

Website

https://www.innovation1bio.com

Innovation1 Biotech Inc is a shell company.

Executives

Grays Peak Llc	10 percent owner	8 THE GREEN, STE. A, DOVER DE 19803
Timothy Orr	director, 10 percent owner, officer: President	4010 TANAGER LANE, #A, MEAD WA 99021
Darren Long	director, 10 percent owner, officer: CEO & Secretary	4010 TANAGER LANE, #A, MEAD WA 99021
Brian Martinho	director, 10 percent owner, officer: Treasurer	4010 EAST TANAGER LANE, MEAD WA 99021